Heterogeneous Responses to Risk Adjustment Reform: Evidence from Dementia Diagnosis in Medicare Advantage
Clicks: 1
ID: 319015
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
1 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #76 of 91 articles by views in Health Affairs Scholar
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Introduction In 2020, Alzheimer’s Disease and Related Dementias (ADRD) diagnoses were reintroduced into the Medicare Advantage (MA) risk adjustment model creating financial incentives that may increase diagnostic coding and plan payments. This effect may vary across plans depending on provider integration, administrative capacity, and geographic context, with implications for payments and potential ‘upcoding’. Methods Using 100% Medicare data from 2016–2021, we estimated event study and difference-in-differences models comparing adjusted trends in incident ADRD diagnoses in MA relative to traditional Medicare before and after the policy change. Results Incident dementia diagnoses increased in MA relative to traditional Medicare, despite an overall downward trend in diagnosis rates. Increases were larger among enrollees in Medicare Advantage health management organization plans (20.8%) than in preferred provider organization plans (7.6%) and varied across insurers, ranging from a 7.2% (UnitedHealthcare) to 21.6% (Kaiser Permanente). Increases were more pronounced in urban than in rural areas. Conclusion Reintroducing ADRD into the MA risk adjustment model was associated with increased diagnostic coding, with substantial variation across plan types, insurers, and geographic contexts. Because ADRD diagnoses increase risk-adjusted payments, larger increases across some plans may reflect coding practices rather than true disease prevalence, highlighting the need for closer monitoring.
| Reference Key |
openalex_W7166346030
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Sidra Haye, Mireille Jacobson, Julie Zissimopoulos |
| Journal | Health Affairs Scholar |
| Year | 2026 |
| DOI |
10.1093/haschl/qxag167
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.